![](https://cdn.sanity.io/images/0vv8moc6/oncnurse/b115970b497b2fa748cb909e900714ca54858b4e-4528x2491.jpg?fit=crop&auto=format)
Perioperative Durvalumab Plus Chemo Shows Promise in Muscle-Invasive Bladder Cancer
Patients with muscle-invasive bladder cancer (MIBC) treated with neoadjuvant durvalumab (Imfinzi) plus gemcitabine and cisplatin, followed by adjuvant durvalumab monotherapy after cystectomy, experienced statistically significant and clinically meaningful …